These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7645871)

  • 1. V beta-specific activation of T-cells by the HIV glycoprotein gp160.
    Akolkar PN; Gulwani-Akolkar B; Chirmule N; Pahwa S; Kalyanaraman VS; Pergolizzi R; Macphail S; Silver J
    Ann N Y Acad Sci; 1995 Jul; 756():447-9. PubMed ID: 7645871
    [No Abstract]   [Full Text] [Related]  

  • 2. Preferential V beta usage by cytotoxic T cells cross-reactive between two epitopes of HIV-1 gp160 and degenerate in class I MHC restriction.
    Shirai M; Vacchio MS; Hodes RJ; Berzofsky JA
    J Immunol; 1993 Aug; 151(4):2283-95. PubMed ID: 7688397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An HIV-1 envelope protein vaccine elicits a functionally complex human CD4+ T cell response that includes cytolytic T lymphocytes.
    Stanhope PE; Liu AY; Pavlat W; Pitha PM; Clements ML; Siliciano RF
    J Immunol; 1993 May; 150(10):4672-86. PubMed ID: 8097759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced immunity to human immunodeficiency virus (HIV) envelope elicited by a combined vaccine regimen consisting of priming with a vaccinia recombinant expressing HIV envelope and boosting with gp160 protein.
    Cooney EL; McElrath MJ; Corey L; Hu SL; Collier AC; Arditti D; Hoffman M; Coombs RW; Smith GE; Greenberg PD
    Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1882-6. PubMed ID: 8446603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of T-cell epitopes without B-cell activity in the first and second conserved regions of the HIV Env protein.
    Sastry KJ; Arlinghaus RB
    AIDS; 1991 Jun; 5(6):699-707. PubMed ID: 1715718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization of mice with human immunodeficiency virus glycoprotein gp160 peptide 315-329 induces both class I- and class II-restricted T cells: not all T cells can respond to whole molecule stimulation.
    Moore RL; Fox BS
    AIDS Res Hum Retroviruses; 1993 Jan; 9(1):51-9. PubMed ID: 7678972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of humoral and cellular immune responses to the human immunodeficiency type 1 virus in nonhuman primates by in vivo DNA inoculation.
    Wang B; Boyer J; Srikantan V; Ugen K; Gilbert L; Phan C; Dang K; Merva M; Agadjanyan MG; Newman M
    Virology; 1995 Aug; 211(1):102-12. PubMed ID: 7645204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computer predictions of antigenic domains in human immunodeficiency virus-1 envelope glycoprotein: comparison with reported experimental data.
    Becker Y
    Virus Genes; 1990 Apr; 3(4):323-41. PubMed ID: 1693457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The HIV glycoprotein gp 160 has superantigen-like properties.
    Akolkar PN; Gulwani-Akolkar B; Chirmule N; Pahwa S; Kalyanaraman VS; Pergolizzi R; Macphail S; Silver J
    Clin Immunol Immunopathol; 1995 Sep; 76(3 Pt 1):255-65. PubMed ID: 7554447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptides containing multideterminant clusters of human immunodeficiency virus envelope induce murine and human T-cell responses in diverse histocompatibility types.
    Berzofsky JA; Pendleton CD; Clerici M; Ahlers J; Lucey DR; Putney SD; Shearer GM
    Trans Assoc Am Physicians; 1991; 104():69-77. PubMed ID: 1845157
    [No Abstract]   [Full Text] [Related]  

  • 11. Clonal analysis of T-cell responses to the HIV-1 envelope proteins in AIDS vaccine recipients.
    Siliciano RF; Bollinger RC; Callahan KM; Hammond SA; Liu AY; Miskovsky EP; Rowell JF; Stanhope PE
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1349-52. PubMed ID: 1361352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to human immunodeficiency virus 1 infection of SCID mice reconstituted with peripheral blood leukocytes from donors vaccinated with vaccinia gp160 and recombinant gp160.
    Mosier DE; Gulizia RJ; MacIsaac PD; Corey L; Greenberg PD
    Proc Natl Acad Sci U S A; 1993 Mar; 90(6):2443-7. PubMed ID: 8460155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization of chimpanzees with the HIV-1 glycoprotein gp160 induces long-lasting T-cell memory.
    Mannhalter JW; Pum M; Wolf HM; Küpcü Z; Barrett N; Dorner F; Eder G; Eibl MM
    AIDS Res Hum Retroviruses; 1991 May; 7(5):485-93. PubMed ID: 1714748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase I evaluation of the safety and immunogenicity of vaccination with recombinant gp160 in patients with early human immunodeficiency virus infection. Military Medical Consortium for Applied Retroviral Research.
    Redfield RR; Birx DL; Ketter N; Tramont E; Polonis V; Davis C; Brundage JF; Smith G; Johnson S; Fowler A
    N Engl J Med; 1991 Jun; 324(24):1677-84. PubMed ID: 1674589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improbability of harmful autoimmune responses resulting from immunization with HIV-1 envelope glycoproteins.
    Neurath AR; Strick N; Li YY; Jiang S
    AIDS Res Hum Retroviruses; 1993 Dec; 9(12):1195-208. PubMed ID: 8142138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of human immunodeficiency virus-specific T cell responses in rhesus monkeys by synthetic peptides from gp160.
    Nehete PN; Satterfield WC; Matherne CM; Arlinghaus RB; Sastry KJ
    AIDS Res Hum Retroviruses; 1993 Mar; 9(3):235-40. PubMed ID: 8471313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 env, nef, and gag-specific T-cell immunity in mice: conserved epitopes in nef p27 and gag p25 proteins.
    Michel F; Hoffenbach A; Froussard P; Langlade-Demoyen P; Kaczorek M; Kieny MP; Plata F
    AIDS Res Hum Retroviruses; 1992 Apr; 8(4):469-78. PubMed ID: 1376136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular aspects concerning antigen oligopeptide selection by MHC class I molecules.
    Drugărin D; Simon Z; Sulea T; Tatu CA
    Roum Arch Microbiol Immunol; 1993; 52(4):267-75. PubMed ID: 7827364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-linked glycans in the CD4-binding domain of human immunodeficiency virus type 1 envelope glycoprotein gp160 are essential for the in vivo priming of T cells recognizing an epitope located in their vicinity.
    Sjölander S; Bolmstedt A; Akerblom L; Horal P; Olofsson S; Morein B; Sjölander A
    Virology; 1996 Jan; 215(2):124-33. PubMed ID: 8560759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement activation by gp160 glycoprotein of HIV-1.
    Thieblemont N; Haeffner-Cavaillon N; Weiss L; Maillet F; Kazatchkine MD
    AIDS Res Hum Retroviruses; 1993 Mar; 9(3):229-33. PubMed ID: 8471312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.